We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

2 hedge funds and large institutions have $2.84M invested in TrovaGene, Inc. Warrant in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more capital invested

Capital invested by funds: $2.18M → $2.84M (+$660K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

50% less funds holding

Funds holding: 42 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$257K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$2.84M +$257K +44,791 +9%
Morgan Stanley
2
Morgan Stanley
New York
-$62K -15,000 Closed
Neuberger Berman Group
3
Neuberger Berman Group
New York
-$62K -15,000 Closed
TRCT
4
Tower Research Capital (TRC)
New York
-$641 -112 -60%

TROVW Hedge Fund Activity: Q3 2013 in Review

2 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2013, worth a combined $2.84M — up 30% from $2.18M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TROVW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Millennium Management, adding an estimated $257K. The largest seller was Morgan Stanley, exiting entirely with an estimated $62K sold.

  • 2 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2013, down from 4 in Q2 2013.
  • Funds reported $2.84M of TrovaGene, Inc. Warrant stock for Q3 2013, up 30% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2013 and 2 closed out, a net change of -2 holders.
  • The largest TrovaGene, Inc. Warrant buyer in Q3 2013 was Millennium Management, an estimated $257K added.
  • The largest TrovaGene, Inc. Warrant seller in Q3 2013 was Morgan Stanley, an estimated $62K sold.

Based on aggregated 13F filings for Q3 2013.